Heart Failure Monitoring
Current gaps in heart failure monitoring make it challenging for clinicians to easily and accurately assess congestion in the home,
Heart Failure: The Challenge
A Common Condition
HF patients/year hospitalized1
Annual cost to US health systems1
Expected cost to US health systems in 20301
A High-Risk Population
Patients with HF often develop volume/intravascular fluid overload (congestion). This fluid imbalance worsens symptoms and is associated with higher rates of hospitalization and readmission.
Compass-HF Trial [N=274]2
Direct relationship between elevated cardiac pressures and hospitalization risk*
*In this trial, researchers demonstrated a direct relationship between elevated cardiac pressures (congestion) and hospitalization risk
“HF monitoring provides important insights into patients' health status. We're working to make those insights accessible to more patients and clinicians.”
PhD, President and CEO, VoluMetrix
Addressing the Gap in Current Monitoring Options
Despite its recognized benefits, hemodynamic monitoring is not utilized for the majority of patients, due to the lack of accurate, non-invasive, low cost, and portable monitoring options.
Direct Measures Are Accurate but Invasive
Because of the invasiveness, inherent risks, and considerable cost of these procedures, they are not widely accessible.
Non-Invasive Measures Are Indirect and Less Accurate
Although these methods are non-invasive and widely accessible, they are imprecise and involve more subjectivity.
The Unmet Need
To enable widespread monitoring of heart failure patients, clinicians need access to non-invasive, point-of-care, portable devices that accurately measure congestion.
A venn diagram. In the left circle it is titled "Accurate", followed by a list: Swan-Ganz PCWP; CaridoMems. In the right circle is titled "Non-Invasive", followed by a list: Clinical symptoms; Daily weight; Input/output; Echocardiographic monitoring; BNP, hemoglobin tests; Chest x-ray. The overlap of the two circles is labled "The Unmet Need".
BNP=B-type natriuretic peptide.
Where Is Monitoring Used?
Healthcare teams managing critical patients use monitoring to assess patient status.
Clinic or Physician's Office
Volume monitoring provides an additional vital sign, similar to blood pressure or heart rate, that can be tracked over time.
Volume monitoring provides deeper insight into the patient's heart failure condition, helping improve awareness of health status.
Defining an Ideal Solution
We asked heart failure clinicians to identify the most important attributes in a hemodynamic monitoring device. Their responses included:
What's your ideal?
Share your feedback on an ideal monitoring solution and help shape the future of HF management.
Join the NIVA Community
We're partnering closely with hospitals, healthcare providers, and patients to make NIVA available. Join our community to stay informed of the latest updates,